Sign in
Taking people in United StatesNo phase

Home Exercise by Video Call for People Receiving Cancer Treatment

Tests a video-guided home exercise program for adults with cancer during treatment.

Key facts

Who runs it
Alliance for Clinical Trials in Oncology
Where
Boston, Butler, Cranberry Township, Dublin, Fremont, Fresno, Indiana, Kernersville, Mechanicsville, Midlothian, Modesto, Mount Airy, New Castle, Oakland, Pittsburgh, Richmond, Sacramento, San Francisco, San Jose, San Rafael, Santa Clara, Santa Rosa, Seneca, Vallejo, Walnut Creek, and Winston-Salem, United StatesSee the 30 sites
Trial code
Registry title
Distance-Based Exercise to Preserve Function and Prevent Disability
Status
Recruiting
People taking part
104 people, planned
Started
11 Feb 2026
Expected to end
31 Aug 2027
Type of study
Interventional
Treatments tested
  • Exercise intervention
  • Telemedicine
  • Aerobic Exercise Intervention
  • Accelerometry
  • Questionnaire Administration
  • Interview
  • Electronic Health Record Review
Record updated
4 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for working adults aged 18 to 64 with a non-metastatic cancer who are starting chemotherapy meant to remove all of the disease. It tests a home exercise program delivered by video calls.

Age
18 to 64 years
Sex
All sexes
Disease stage
Confirmed cancer of the anus, bladder, breast, cervix, colon/rectum, endometrium, esophagus, gallbladder, head/neck, kidney, liver, lung, ovary, pancreas, prostate, sarcoma or stomach. The cancer must not be metastatic.
Earlier treatment
Starting outpatient chemotherapy (with or without radiation, immunotherapy or targeted therapy) of at least 10 weeks, given to remove all of the disease. Enrolment must happen on or before the second chemotherapy cycle. Immunotherapy or monoclonal antibodies alone do not count.

Main reasons for not taking part

  • Metastatic cancer
  • Severe heart, lung, muscle or joint disease that rules out moderate physical activity
  • Pregnant or breast-feeding
  • Current alcohol or substance abuse, or dementia
  • Competitive sports, or regular resistance training in the past year

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Participants must have histologically confirmed diagnosis of one of the following cancers: anus, bladder, breast, cervix, colon/rectum, endometrium, esophagus, gallbladder, head/neck, kidney, liver, lung, ovary, pancreas, prostate, sarcoma, stomach
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Participants must be initiating outpatient cytotoxic chemotherapy for curative intent of at least 10 weeks duration (with or without concurrent radiation, immunotherapy, or other targeted therapy). Patients must be enrolled and baseline measures collected on or before administration of their second cycle of cytotoxic therapy. Patients receiving outpatient cytotoxic chemotherapy for curative intent in the neoadjuvant or adjuvant setting are eligible. Patients receiving definitive chemoradiation for the tumors listed above, are also eligible. Regimens of immunotherapy or monoclonal antibodies ONLY are not eligible
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Age 18-64 years
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have metastatic cancer
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have documentation in the medical record of severe cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity. Examples would include unstable angina, recent myocardial infarction, oxygen-dependent pulmonary disease, and osteoarthritis requiring imminent joint replacement. Moderate arthritis that does not preclude physical activity is not a reason for ineligibility
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot be pregnant, because this study involves remotely delivered exercise, and cannot be breast-feeding as patients must be receiving cytotoxic chemotherapy, during which breast-feeding is contraindicated
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have documentation in the medical record of current alcohol, substance abuse, or dementia
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Engaged in full time gainful employment of at least 30 hours per week at the time of cancer diagnosis
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Currently no self-report of engagement in competitive sports (e.g. not training for running races, triathlons, etc.) AND no self-report of twice weekly progressive resistance exercise training for at least 3 consecutive months within the past year
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Self-reported ability to walk for 6 minutes (use of assistive devices will be allowed)
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Not participating in another weight loss, physical activity, or dietary intervention clinical trial
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Predicted 6MWT distance of 550 meters or less
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Concurrent enrollment in treatment or supportive care trials (other than those focused on weight loss or exercise) is allowed with the permission of the Alliance Executive Officer and both studies' study chairs
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Eligibility is restricted to individuals who can comprehend and read English given that participation in the study will require the ability to read intervention materials and work with a coach through telehealth sessions
  • REGISTRATION ELIGIBILITY CRITERIA (STEP 1): The trial is unable to accommodate the needs of deaf or blind participants as the study relies on language and visualization of exercise through telehealth sessions
  • CLINICAL STAKEHOLDER ELIGIBILITY CRITERIA: Clinicians and research staff from enrolling sites who meet following criterion will be deemed eligible to participate as a clinical stakeholder:; Providing clinical care for participating patients on this study
  • CLINICAL STAKEHOLDER ELIGIBILITY CRITERIA: Ability to speak and understand English

Who cannot take part

  • -

Where in United States

  • Dana-Farber Cancer InstituteBoston, United StatesContact: Jennifer A. Ligibel (principal investigator)Taking people
  • UPMC Hillman Cancer Center at Butler Health SystemButler, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • UPMC Hillman Cancer Center - Passavant - CranberryCranberry Township, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • Kaiser Permanente DublinDublin, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente-FremontFremont, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente Fresno Orchard PlazaFresno, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • IRMC Cancer CenterIndiana, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • Novant Health Cancer Institute - KernersvilleKernersville, United StatesContact: Judith O. Hopkins (principal investigator)Taking people
  • Bon Secours Memorial Regional Medical CenterMechanicsville, United StatesContact: William J. Irvin (principal investigator)Taking people
  • Bon Secours Saint Francis Medical CenterMidlothian, United StatesContact: William J. Irvin (principal investigator)Taking people
  • Kaiser Permanente- Modesto MOB IIModesto, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente-ModestoModesto, United StatesContact: Lilli JohnsonNo longer taking part
  • Novant Health Cancer Institute - Mount AiryMount Airy, United StatesContact: Judith O. Hopkins (principal investigator)Taking people
  • UPMC Hillman Cancer Center - New CastleNew Castle, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • Kaiser Permanente-OaklandOakland, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • UPMC Hillman Cancer CenterPittsburgh, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • UPMC-Magee Womens HospitalPittsburgh, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • UPMC-Passavant HospitalPittsburgh, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • UPMC-Saint Clair Hospital Cancer CenterPittsburgh, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • Bon Secours Saint Mary's HospitalRichmond, United StatesContact: William J. Irvin (principal investigator)Taking people
  • Kaiser Permanente-South SacramentoSacramento, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente-San FranciscoSan Francisco, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente-Santa Teresa-San JoseSan Jose, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser San Rafael-GallinasSan Rafael, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente Medical Center - Santa ClaraSanta Clara, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente-Santa RosaSanta Rosa, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • UPMC Cancer Center at UPMC NorthwestSeneca, United StatesContact: Kathryn Schmitz (principal investigator)Taking people
  • Kaiser Permanente-VallejoVallejo, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Kaiser Permanente-Walnut CreekWalnut Creek, United StatesContact: Jennifer M. Suga (principal investigator)Taking people
  • Novant Health Forsyth Medical CenterWinston-Salem, United StatesContact: Judith O. Hopkins (principal investigator)Taking people

About the trial

What the trial wants to find out

This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side effects can make it difficult to work, take care of family, and do other things the patient wants to do. Preliminary research shows that exercise can help prevent some of these side effects, but it can be more difficult to start an exercise program when a patient is receiving cancer treatment. The exercise program in this study is delivered through telehealth (TH) video calls. The TH sessions are delivered by trained staff that supervise resistance exercises. The trained staff also provide guidance to the patient on completing unsupervised aerobic sessions on their own. This may be a successful way to deliver an exercise program and make it easier for cancer patients to exercise in their own home during treatment.

The group in the trial

  • Supportive care (DEFEND)Treatment being tested

    Patients complete supervised TH exercise sessions consisting of progressive resistance exercise BIW and complete unsupervised aerobic exercise sessions over 30 minutes TIW until the end of SOC chemotherapy or up to a total of 6 months, whichever comes first, in the absence of disease progression or unacceptable toxicity. Patients also receive adjustable-weight dumbbells on study and wear an accelerometer throughout the study.

    Treatment: Exercise intervention, Telemedicine, Aerobic Exercise Intervention, Accelerometry, Questionnaire Administration, Interview, and Electronic Health Record Review

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Distance-Based Exercise to Preserve Function and Prevent Disability
Plain-language title
Home Exercise by Video Call for People Receiving Cancer TreatmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
4 November 2026